Concepedia

Llewelyn Lao

LL

Statistics

Publications

6

Citations

153

H-Index

6

Active since

2013

Affiliations

XOMA (United States)(Current)

University of California, San Francisco

Llewelyn Lao is an author at XOMA (United States) specializing in oncology, immunology, and immunotherapy.

Publications per year

2013–2024

6

Publications

6

Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms

Daniel Bedinger, Llewelyn Lao, Shireen Khan et al. · mAbs · 2015 · 42 citations · Full text

Pharmacy, Immunology, Oncology +17

HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

Mary E. Molloy, Wade H. Aaron, Manasi Barath et al. · Molecular Cancer Therapeutics · 2024 · 29 citations · Full text

Life Sciences, Immunology, Oncology +17

Inhibition of insulin receptor function by a human, allosteric monoclonal antibody

John Corbin, Vinay Bhaskar, Ira D. Goldfine et al. · mAbs · 2013 · 28 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Improved Glucose Metabolism In Vitro and In Vivo by an Allosteric Monoclonal Antibody That Increases Insulin Receptor Binding Affinity

John Corbin, Vinay Bhaskar, Ira D. Goldfine et al. · PLoS ONE · 2014 · 21 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Preclinical and Nonclinical Characterization of HPN217: A Tri-Specific T Cell Activating Construct (TriTAC) Targeting B Cell Maturation Antigen (BCMA) for the Treatment of Multiple Myeloma

Che‐Leung Law, Wade H. Aaron, Rick Austin et al. · Blood · 2018 · 19 citations

Life Sciences, Immunology, Oncology +14

1–5 of 6